Intuitive Surgical ISRG

Intuitive Surgical (ISRG) has faced a significant decline in its stock, dropping 20% this year amid concerns over weakening demand from hospitals. Despite reporting strong fourth-quarter revenues of $1.55 billion and a non-GAAP net income of $477 million, investor sentiment has soured due to management's cautious outlook. The company's stock has plummeted by 33.5% over recent months, raising alarms about the impact of financial strains in the healthcare sector and the lingering effects of the coronavirus pandemic. While Intuitive Surgical retains over 79% market share in robotic-assisted surgery and projects a procedure growth of 12% to 16%, the pressures on hospital demand continue to overshadow its financial strengths.